Clinical Trials Logo

Contracture clinical trials

View clinical trials related to Contracture.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04834310 Withdrawn - Clinical trials for Surgical Site Infection

Postoperative Antibiotics Following Primary and Secondary Breast Augmentation

Start date: April 1, 2021
Phase: Phase 4
Study type: Interventional

Postoperative antibiotics are routinely used for implant-based breast augmentation at the investigators' institution. From 2017-2019, the investigators' institution has conducted approximately 270 primary and secondary breast augmentation procedures. Current plastic surgery literature does not provide recommendations for antibiotic prophylaxis following implant-based breast procedures. Despite controversy surrounding their utility during the postoperative course, postoperative antibiotics have become commonplace for many plastic surgeons. To date, strong scientific evidence supporting this practice is minimal and based largely on anecdotal evidence and limited studies, including poorly controlled retrospective and non-blinded prospective series. The goal of this study is to conduct a prospective randomized trial to assess whether extended antibiotic prophylaxis is necessary to prevent infection and long-term complications (e.g. capsular contracture) in patients undergoing augmentation mammoplasty with implants. The investigators' anticipate that extended antibiotic prophylaxis is not required. The rationale for discontinuing postoperative antibiotics is based on the following: (1) a single dose of preoperative intravenous antibiotics has been demonstrated to be sufficient prophylaxis for most breast surgeries and (2) there are patient safety concerns associated with prolonged antimicrobial use such as the development of resistant bacterial strains and clostridium-related infections. Concrete evidence that extended antibiotic prophylaxis is not required would encourage plastic surgeons to practice better antibiotic stewardship and help stymie the rise of drug-resistant organisms.

NCT ID: NCT03031080 Withdrawn - Clinical trials for Dupuytren Contracture

BOND Study: the Benefit Of Night Splinting in Dupuytrens'

BOND
Start date: June 1, 2017
Phase: N/A
Study type: Interventional

The BOND study is a prospective, randomised single blinded controlled trial to assess the effect of night splinting in patients who have had collagenase injection and manipulation therapy for Dupuytren's Contracture.

NCT ID: NCT01776892 Withdrawn - Clinical trials for Dupuytren Contracture

Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease

Start date: May 2013
Phase: Phase 3
Study type: Interventional

Dupuytren's disease results in deformity of the hand and this can lead to trouble with daily activities. Treatment traditionally involves cutting out diseased tissue, however this can cause damage to important structures in the hand and results in large scars. Needle aponeurotomy and collagenase injections are newer treatments that are thought to be safer. These treatments allow quicker return to function. One drawback is that Dupuytren's deformity may return more quickly than when all diseased tissue is surgically cut out. This research study is designed to compare the effectiveness of needle aponeurotomy and collagenase injection for Dupuytren's disease. This study will determine which procedure gives the best results- either needle aponeurotomy, collagenase injection, or both procedures in combination. Participants will be evaluated to see how they do in the long term.

NCT ID: NCT01320124 Withdrawn - Osteoarthritis Clinical Trials

Creating a Tissue Bank of Knee Capsules

Start date: March 2011
Phase: N/A
Study type: Observational

A contracture is a pathological condition limiting range and function of joints. Contractures of large and small joints alike will affect one's ability to independently perform daily activities such as eating, dressing or walking. Current treatments for contractures include physical stretching, the use of assistive devices or, rarely, surgery. Despite prolonged treatments, patients with contractures rarely regain complete mobility. Progress in preventing and treating contractures will be possible only through an understanding of the biological and molecular processes involved. Our group has established and validated an animal model to study the histological events and the molecular mechanisms involved in joint contractures. We have provided evidence for capsule stiffness, characterized cartilage degeneration, and identified four genes whose expression is altered in the cartilage of a knee joint with contracture. The work we propose in the current study aims at finding genes and pathways in the joint capsule associated with knee joint contractures. The results will identify new avenues for treating the large number of patients suffering from contractures.

NCT ID: NCT00900692 Withdrawn - Clinical trials for Pronation Contracture

Dynamic Splinting for Excessive Pronation Following CVA

SupPro Botox
Start date: May 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to examine range of motion and lasting effects of Botox injections along with the use of the Supination Dynasplint.

NCT ID: NCT00664651 Withdrawn - Joint Contracture Clinical Trials

Joint Stiffness Following Knee Replacement Surgery

Start date: December 2006
Phase: N/A
Study type: Observational

Our primary research question is to find out whether there is a genetic component to the development of joint contractures following knee surgery, through the application of lab techniques.